Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 TAILORx: trial assigning individualized options for treatment (Rx).

× No keyword cloud information.

91 in total

1. Transforming the practice of medicine using genomics.

Authors: Geoffrey S Ginsburg; Geoffrey S Ginsburg; Jeanette J McCarthy
Journal: Clin Cases Miner Bone Metab Date: 2009-01

Review 2. Gene-expression-based prognostic assays for breast cancer.

Authors: Chungyeul Kim; Soonmyung Paik
Journal: Nat Rev Clin Oncol Date: 2010-05-04 Impact factor: 66.675

3. Why does Oncotype DX recurrence score reduce adjuvant chemotherapy use?

Authors: Jeffrey G Schneider; Danny N Khalil
Journal: Breast Cancer Res Treat Date: 2012-06-22 Impact factor: 4.872

4. The Promise and the Problems of Epigenetics Biomarkers in Cancer.

Authors: Attila T Lorincz
Journal: Expert Opin Med Diagn Date: 2011-09-01

Review 5. Biomarker enrichment strategies: matching trial design to biomarker credentials.

Authors: Boris Freidlin; Edward L Korn
Journal: Nat Rev Clin Oncol Date: 2013-11-26 Impact factor: 66.675

Review 6. Clinical utility of gene-expression signatures in early stage breast cancer.

Authors: Maryann Kwa; Andreas Makris; Francisco J Esteva
Journal: Nat Rev Clin Oncol Date: 2017-05-31 Impact factor: 66.675

7. Emerging gene-based prognostic tools in early breast cancer: First steps to personalised medicine.

Authors: Umar Wazir; Kefah Mokbel
Journal: World J Clin Oncol Date: 2014-12-10

8. Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancer.

Authors: Michael J Hassett; Melissa E Hughes; Joyce C Niland; Stephen B Edge; Richard L Theriault; Yu-Ning Wong; John Wilson; W Bradford Carter; Douglas W Blayney; Jane C Weeks
Journal: J Clin Oncol Date: 2008-10-27 Impact factor: 44.544

9. Breast carcinoma with an Oncotype Dx recurrence score <18: Rate of distant metastases in a large series with clinical follow-up.

Authors: Hannah Y Wen; Melissa Krystel-Whittemore; Sujata Patil; Fresia Pareja; Zenica L Bowser; Maura N Dickler; Larry Norton; Monica Morrow; Clifford A Hudis; Edi Brogi
Journal: Cancer Date: 2016-08-15 Impact factor: 6.860

10. Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.

Authors: Olivia Pagani; Shari Gelber; Edda Simoncini; Monica Castiglione-Gertsch; Karen N Price; Richard D Gelber; Stig B Holmberg; Diana Crivellari; John Collins; Jurij Lindtner; Beat Thürlimann; Martin F Fey; Elizabeth Murray; John F Forbes; Alan S Coates; Aron Goldhirsch
Journal: Breast Cancer Res Treat Date: 2008-10-25 Impact factor: 4.872